[HTML][HTML] Systematic evaluation of the evidence for identification of endocrine disrupting properties of Bisphenol F

L Wiklund, A Beronius - Toxicology, 2022 - Elsevier
Identification of endocrine disruptors (EDs) is a highly prioritized issue in the EU. However,
scientific criteria to identify EDs have so far only been implemented for biocidal and plant …

Assessment of the endocrine disrupting properties of Bisphenol AF according to the EU criteria and ECHA/EFSA guidance

Karolinska Institutet, Institute of Environmental … - EFSA …, 2019 - Wiley Online Library
Endocrine disruptors (ED s) are exogenous compounds that interfere with the hormone
system, affecting human health and environment. Specific legislative obligations have been …

Assessment of the endocrine disrupting properties of bisphenol AF: a case study applying the European regulatory criteria and guidance

L Escrivá, J Zilliacus, E Hessel, A Beronius - Environmental Health, 2021 - Springer
Background Scientific criteria to identify endocrine disruptors (ED) was recently
implemented for plant protection products (PPP) and biocidal products (BP). A guidance …

Update on the health effects of bisphenol A: overwhelming evidence of harm

FS Vom Saal, LN Vandenberg - Endocrinology, 2021 - academic.oup.com
In 1997, the first in vivo bisphenol A (BPA) study by endocrinologists reported that feeding
BPA to pregnant mice induced adverse reproductive effects in male offspring at the low dose …

Evidence for bisphenol B endocrine properties: scientific and regulatory perspectives

H Serra, C Beausoleil, R Habert, C Minier… - Environmental …, 2019 - ehp.niehs.nih.gov
Background: The substitution of bisphenol A (BPA) by bisphenol B (BPB), a very close
structural analog, stresses the need to assess its potential endocrine properties. Objective …

Regulatory and academic studies to derive reference values for human health: the case of bisphenol S

C Beausoleil, B Le Magueresse-Battistoni… - Environmental …, 2022 - Elsevier
The close structural analogy of bisphenol (BP) S with BPA, a recognized endocrine-
disrupting chemical and a substance of very high concern in the European Union, highlights …

Low dose effects of bisphenol A: An integrated review of in vitro, laboratory animal, and epidemiology studies

LN Vandenberg, S Ehrlich, SM Belcher… - Endocrine …, 2013 - Taylor & Francis
In 2007, a group of experts critically analyzed hundreds of publications on bisphenol A
(BPA), including the evidence for low dose effects. Here, we have updated these evaluations …

Subacute oral toxicity study of bisphenol F based on the draft protocol for the “Enhanced OECD Test Guideline no. 407”

N Higashihara, K Shiraishi, K Miyata, Y Oshima… - Archives of …, 2007 - Springer
Abstract Since bisphenol F (4, 4'-dihydroxydiphenylmethane) has been reported to exhibit
estrogen agonistic properties in the uterotrophic assay, we performed a 28-day repeated …

Occurrence, toxicity and endocrine disrupting potential of Bisphenol-B and Bisphenol-F: A mini-review

A Usman, S Ikhlas, M Ahmad - Toxicology Letters, 2019 - Elsevier
Recent imposition of restriction on the use of Bisphenol-A (BPA) paved the way for entry of
its analogues in the market. Bisphenol-B and Bisphenol-F are the major analogues of …

Bisphenol S and F: a systematic review and comparison of the hormonal activity of bisphenol A substitutes

JR Rochester, AL Bolden - Environmental health perspectives, 2015 - ehp.niehs.nih.gov
Background Increasing concern over bisphenol A (BPA) as an endocrine-disrupting
chemical and its possible effects on human health have prompted the removal of BPA from …